Key result
Pulsed-field ablation for paroxysmal atrial fibrillation yielded comparable arrhythmia recurrence rates to CF-RFA (23.90% vs 23.72%) and 2G-CBA (25.56%), with shorter procedure times than CF-RFA.
Why the study?
Pulsed-field ablation is a novel nonthermal modality for AF that may reduce procedural complications compared with conventional thermal ablation methods.
Does pulsed-field ablation reduce arrhythmia recurrence and complications compared to CF-RFA and 2G-CBA in patients with paroxysmal atrial fibrillation?
Meta-Analysis
Does pulsed-field ablation reduce arrhythmia recurrence and complications compared to CF-RFA and 2G-CBA in patients with paroxysmal atrial fibrillation?
Absolute Event Rate: 23.9% vs 23.72%
Pulsed-field ablation demonstrates comparable efficacy and safety to established thermal ablation techniques for paroxysmal atrial fibrillation, with potentially shorter procedure times and lower risk of phrenic nerve palsy.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“We are very pleased by the strong enrollment trajectory in the NANOPULSE-AF study. Reaching this midpoint milestone so quickly reflects the enthusiasm of our investigational sites for this technology and its potential to deliver leading durability in pulmonary vein isolation, procedural efficiency and consistent safe and effective patient outcomes.”
“The nPulse System has been a remarkably intuitive platform to work with. The learning curve is minimal, and the workflow integrates seamlessly into our existing ablation practice... That ease of use is a meaningful driver of the momentum we're seeing in enrollment, and the nPulse System has already demonstrated the potential to be a safe and durable treatment option for our patients.”
“APAC faces a growing burden of AFib at a time when healthcare systems are under increasing pressure to deliver high quality care more efficiently. Growing confidence in PFA presents an important opportunity to transform AFib care, but we must work together to address education and referral gaps so that more eligible patients can benefit from this technology.”
Supports PFA as alternative to CF-RFA with comparable recurrence; confirms efficacy equivalence in this RCT.
Introduction Pulsed‐field ablation (PFA) is a novel, nonthermal modality for the treatment of atrial fibrillation (AF) that may reduce procedural complications compared with conventional thermal ablation methods. Methods and Results A systematic literature review was conducted to identify studies comparing PFA with second‐generation cryoballoon ablation (2G‐CBA) and contact force‐sensing radiofrequency ablation (CF‐RFA) for paroxysmal AF (pAF) from the inception of PFA to January 2026. A single‐arm meta‐analysis was performed using random‐effects models, reporting the arcsine of the square root transformation (PAS) or mean (95% CI) for each intervention. Overall, 29 studies (9 randomized controlled trials and 20 observational studies) were included. Arrhythmia recurrence rates were comparable across all three interventions [PFA: 23.90% (PAS 0.24, 95% CI 0.19–0.29, p < 0.0001); CF‐RFA: 23.72% (PAS 0.24, 95% CI 0.19–0.29, p < 0.0001); 2G‐CBA: 25.56% (PAS 0.26, 95% CI 0.20–0.31, p < 0.001)]. Overall procedure time was significantly shorter with PFA than with CF‐RFA and comparable to 2G‐CBA [PFA: mean 87.66 min (95% CI 74.29–101.04, p < 0.001); CF‐RFA: mean 137.54 min (95% CI 123.65–151.43, p < 0.001); 2G‐CBA: mean 105.56 min (95% CI 89.93–121.18, p < 0.001)]. Fluoroscopy time was shorter with PFA than with 2G‐CBA but comparable to CF‐RFA [PFA: mean 16.12 min (95% CI 12.36–19.88); CF‐RFA: mean 17.28 min (95% CI 13.59–20.98); 2G‐CBA: mean 22.08 min (95% CI 18.23–25.94)]. Overall complication rates did not differ significantly among the three interventions [PFA: 2.93% (95% CI 1.87–4.22%); CF‐RFA: 3.66% (95% CI 1.84–6.07%); 2G‐CBA: 6.52% (95% CI 4.41–9.00%)]. The incidence of phrenic nerve palsy was significantly higher with 2G‐CBA than with PFA or CF‐RFA. Conclusion PFA demonstrated comparable efficacy and safety to CF‐RFA and 2G‐CBA, with a numerically shorter procedure time than CF‐RFA and a lower incidence of phrenic nerve palsy than 2G‐CBA, supporting PFA as a viable alternative to established ablation techniques for pAF.
No takes yet. Share an insight, caveat, or question.
Oudih et al. (2026) conducted a meta-analysis in Paroxysmal atrial fibrillation. Pulsed-field ablation (PFA) vs. Contact force-sensing radiofrequency ablation (CF-RFA) and second-generation cryoballoon ablation (2G-CBA) was evaluated on Arrhythmia recurrence rates. Pulsed-field ablation for paroxysmal atrial fibrillation yielded comparable arrhythmia recurrence rates to CF-RFA (23.90% vs 23.72%) and 2G-CBA (25.56%), with shorter procedure times than CF-RFA.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: